Antimicrobial resistance (AMR) is an escalating global threat, with a manifold of drivers and mechanisms. In human medicine, antimicrobials are the most frequently prescribed drugs and resistance means their benefits could soon be compromised.
A collaborative approach is needed, both to optimise current antimicrobial use and to invest in the development of novel drugs. At this event, we will host academics and industry experts to explain the factors that have led to the spread of AMR, articulate the impacts of AMR on a public and global scale and elucidate the alternative approaches that are in development.
A panel discussion will follow on from the talks, and will be open for attendees to contribute. This event promises to nurture research ideas among fellow scientists and encourage collaborations between academia and business.
Andrew’s research focuses on ascertaining the molecular basis of treatment refractory infections and developing therapeutic solutions to overcome antibiotic resistance and tolerance.
Nicole's focus is on developing high-throughput computational methods for understanding adaptation in bacterial pathogens, and flagging high-risk strains. She combines a background in biochemistry and genetics with experience in statistics and machine learning to find new ways to gain insight from genome sequence data.
Silvia’s research is based on the analysis of pathogen genome sequences in terms of global surveillance and antimicrobial resistance, which assists the development of pathogen surveillance in a public health context.
Thursday, July 23rd 2020
18:00 – 21:00 (GMT)